BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14967536)

  • 1. Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors.
    Gupta AK; Curtis AS
    Biomaterials; 2004 Jul; 25(15):3029-40. PubMed ID: 14967536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis.
    Gupta AK; Berry C; Gupta M; Curtis A
    IEEE Trans Nanobioscience; 2003 Dec; 2(4):255-61. PubMed ID: 15376916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture.
    Gupta AK; Curtis AS
    J Mater Sci Mater Med; 2004 Apr; 15(4):493-6. PubMed ID: 15332623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
    Gupta AK; Gupta M
    Biomaterials; 2005 May; 26(13):1565-73. PubMed ID: 15522758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells.
    Petri-Fink A; Chastellain M; Juillerat-Jeanneret L; Ferrari A; Hofmann H
    Biomaterials; 2005 May; 26(15):2685-94. PubMed ID: 15585272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro.
    Berry CC; Wells S; Charles S; Curtis AS
    Biomaterials; 2003 Nov; 24(25):4551-7. PubMed ID: 12950997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
    Gupta AK; Gupta M
    Biomaterials; 2005 Jun; 26(18):3995-4021. PubMed ID: 15626447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell response to dextran-derivatised iron oxide nanoparticles post internalisation.
    Berry CC; Wells S; Charles S; Aitchison G; Curtis AS
    Biomaterials; 2004 Oct; 25(23):5405-13. PubMed ID: 15130725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of elastin-coated 520-nm- and 20-nm-diameter nanoparticles on human fibroblasts in vitro.
    Berry CC; Rudershausen S; Teller J; Curtis AS
    IEEE Trans Nanobioscience; 2002 Sep; 1(3):105-9. PubMed ID: 16696299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation.
    Buyukhatipoglu K; Clyne AM
    J Biomed Mater Res A; 2011 Jan; 96(1):186-95. PubMed ID: 21105167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro cytotoxicity and cell uptake study of gelatin-coated magnetic iron oxide nanoparticles.
    Gaihre B; Hee Lee Y; Khil MS; Yi HK; Kim HY
    J Microencapsul; 2011; 28(4):240-7. PubMed ID: 21545315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
    Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
    ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
    Gupta AK; Naregalkar RR; Vaidya VD; Gupta M
    Nanomedicine (Lond); 2007 Feb; 2(1):23-39. PubMed ID: 17716188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.
    Kohler N; Sun C; Wang J; Zhang M
    Langmuir; 2005 Sep; 21(19):8858-64. PubMed ID: 16142971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
    Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
    Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-mediated targeted delivery of DNA using Lactoferrin nanoparticles.
    Kumari S; Kondapi AK
    Int J Biol Macromol; 2018 Mar; 108():401-407. PubMed ID: 29191424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization and functionalization of iron oxide nanoparticles for biomedical applications.
    Amstad E; Textor M; Reimhult E
    Nanoscale; 2011 Jul; 3(7):2819-43. PubMed ID: 21629911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of interaction of magnetic nanoparticles with breast cancer cells.
    Calero M; Chiappi M; Lazaro-Carrillo A; Rodríguez MJ; Chichón FJ; Crosbie-Staunton K; Prina-Mello A; Volkov Y; Villanueva A; Carrascosa JL
    J Nanobiotechnology; 2015 Feb; 13():16. PubMed ID: 25880445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of aqueous dispersions of Fe(3)O(4) nanoparticles and their biomedical applications.
    Cheng FY; Su CH; Yang YS; Yeh CS; Tsai CY; Wu CL; Wu MT; Shieh DB
    Biomaterials; 2005 Mar; 26(7):729-38. PubMed ID: 15350777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of lytic peptide-bound magnetite nanoparticles in destroying breast cancer cells.
    Kumar CS; Leuschner C; Doomes EE; Henry L; Juban M; Hormes J
    J Nanosci Nanotechnol; 2004 Mar; 4(3):245-9. PubMed ID: 15233083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.